Skip to main content

by Proactive

Go to Proactive UK i

Proactive’s coverage of London’s small caps continues on .com

Pharma & Biotech

RespireRx Pharmaceuticals is developing innovative and revolutionary treatments to combat neuronal signaling disorders

Proactive Published 10/03/2022

Share X in f @

Article originally published by Proactive: visit Proactive to find out more, including T&Cs.

Explore

Big caps
Insight
What brokers say
Small caps
Retail & consumer
Movers (standalone)
Finance
Tech
Mid caps
Mining

All stories ›

The Markets by Proactive

© 2026 The Markets Proactive UK continues on proactiveinvestors.com

Sections

Latest
Search

The newsroom

Editorial desk
About
Editorial standards
Corrections

Legal

Privacy
Terms
Contact